Open access
Jul 2026
Novel blood lncRNA biomarkers associated with clinical severity and specific cognitive dimensions in Alzheimer's disease
This work identifies candidate lncRNAs that may serve as potential biomarkers and enhance the understanding of the molecular basis of the cognitive architecture in AD, opening new avenues for biomarker identification and targeted therapeutic strategies development.
María I. Mosquera-Heredia, Oscar M. Vidal, E. Barceló et al.
· Journal of Alzheimer's Disea... · 0 citations